Skip to main content

MoneyWorks4Me

Lupin informs about board meeting

23 Jan 2017 Evaluate

Lupin has informed that a meeting of the Board of Directors of the Company will be held on February 09, 2017, to consider and take on record the unaudited financial results for the quarter ended December 31, 2016 (Q3).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1763.00
Dr. Reddys Labs. 1310.85
Cipla 1344.65
Lupin 1951.60
Zydus Lifesciences 1169.40
View more..